| 1. |
 3 |
Amizon (Farmak)
|
22.89% |
5 |
|
|
| 2. |
5 |
Фармацитрон (Pharmascience)
|
24.10% |
4.96 |
|
|
| 3. |
 1 |
Афлубін (Perrigo)
|
21.69% |
4.79 |
|
|
| 4. |
2 |
Фервекс (Bristol-Myers Squibb)
|
15.66% |
3.42 |
|
|
| 5. |
4 |
Терафлю (Novartis OTC)
|
14.46% |
3.26 |
|
|
| 6. |
9 |
Флюколд-N (Nabros Pharma) |
15.66% |
3.16 |
|
|
| 7. |
 |
Маліпін (Vishpha | Фармацевтична фабрика Vishpha)
|
13.25% |
3.08 |
|
|
| 8. |
10 |
Анаферон (Materia Medica – Ukraine)
|
13.25% |
2.96 |
|
|
| 9. |
6 |
Колдрекс (GlaxoSmithKline)
|
12.05% |
2.42 |
|
|
| 10. |
7 |
Хелпекс (Movi Health GmbH) 
|
10.84% |
2.17 |
|
|
| 11. |
26 |
Розтиран (Vishpha | Фармацевтична фабрика Vishpha)
|
8.43% |
1.97 |
|
|
| 12. |
14 |
Antiflu (Bayer)
|
8.43% |
1.95 |
|
|
| 12. |
15 |
Arbidol (OTC-Фарм) |
8.43% |
1.95 |
|
|
| 14. |
11 |
Грип-Хеель (Heel)
|
7.23% |
1.75 |
|
|
| 14. |
8 |
Мілістан (Mili Healthcare) |
8.43% |
1.75 |
|
|
| 16. |
22 |
Колдфлю Екстра (Genom Biotech) |
8.43% |
1.65 |
|
|
| 16. |
12 |
Ergoferon (Materia Medica – Ukraine)
|
7.23% |
1.65 |
|
|
| 18. |
25 |
IRS 19 (Abbott Laboratories)
|
7.23% |
1.55 |
|
|
| 19. |
16 |
Комбігрип (ORGANOSYN)
|
6.02% |
1.15 |
|
|
| 20. |
21 |
Gripex (Delta Medical)
|
6.02% |
1.11 |
|
|
| 21. |
18 |
Грипомед (Red star)
|
4.82% |
1.10 |
|
|
| 22. |
17 |
Інсті (Herbion) |
3.61% |
0.90 |
|
|
| 22. |
13 |
Антигрипін (Національна гомеопатична спілка) |
3.61% |
0.90 |
|
|
| 24. |
19 |
Гриппостад (Nizhpharm)
|
3.61% |
0.80 |
|
|
| 24. |
|
Вікс Актив (Dr. Reddy’s)
|
3.61% |
0.80 |
|
|
| 26. |
23 |
Ринза (Johnson & Johnson)
|
3.61% |
0.70 |
|
|
| 27. |
25 |
Rinicold (Shreya Life Sciences) |
2.41% |
0.40 |
|
|
| 28. |
22 |
Грипмакс (Unipharm, Inc)
|
1.20% |
0.30 |
|
|
| 28. |
24 |
Колдрін (Teva)
|
1.20% |
0.30 |
|
|
The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.
View results of current, 2024 year
Show all preparations
RSS-feed